| We are a National Coalition of AIDS Activists, many living with HIV/AIDS, working together to end the AIDS epidemic by advancing research on HIV/AIDS. |
Tibotec
ATAC DDC Liaisons: Rob Camp and Heidi Nass
CONTACT INFORMATION
NOTE: Tibotec is a semi-independent research and development company owned by Johnson & Johnson.
Community Contact:
Lew Sibert, Senior Director, Medical & Professional Affairs
1199 Shipwatch Circle
Tampa, FL 33602
Telephone: (813) 390-1333
Fax: (813) 223-2208
E-mail: [email protected]
PRODUCT INFORMATION
- FDA-Approved Products:
- Products in Development:
- HIV non-nucleoside reverse transcriptase inhibitors (TMC125, TMC278)
- HIV protease inhibitor (TMC114)
Web page: http://www.tibotec.com
Contact: [email protected]
KEY PERSONNEL
- Roger Pomerantz, M.D., President
- Wim Parys, M.D., VP, Global Clinical Development
- Marie-Pierre de Bethune, PhD, Vice President, Research Virology
- Karen Manson, Vice President, Corporate Communications
- Lew Sibert, Sr. Director, Medical & Professional Affairs
- Eric Lefebvre, M.D., Global Medical Leader TMC114
- Brian Woodfall, M.D., Global Medical Leader, TMC125, TMC278
- David McNeeley, M.D., Global Medical Leader, TMC207
|
|